J3244 Inj. tigecycline (accord)

Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for J3244

Physician Fee Schedule (CY 2026, RVU26D)

Status E: excluded from the PFS by regulation.

Payer policies and prior authorization for J3244

Payer coverage policies that name J3244

J3244 appears in 1 coverage policy from Aetna.

PayerPolicyRole in policyReviewedDocument
AetnaInjectable Medications (0020)listed, no stance (range J2550-J3520)Mar 5, 2026payer document

Medicaid fee-for-service

Prior authorization required or conditional in VT.

  • AZ: $2.50 (outpatient_hospital), effective Oct 1, 2025
  • IN: $2.24 (professional, Advanced Practice Nurse (85%), non-facility), effective Jan 1, 2023
  • KS: $2.50 (default), effective Jan 1, 2023
  • KY: $0.00 (asc), effective Jan 1, 2026
  • LA: $2.50 (professional), effective Jan 1, 2023
  • NE: $2.67 (injectables), effective Jul 1, 2026
  • OH: $0.60 (provider_administered_drugs), effective Apr 1, 2023
  • OK: $0.60 (physician, non-facility), effective Jul 1, 2026
  • TX: $2.87 (nurse_practitioner_clinical_nurse_specialist, Nurse Practitioner/Clinical Nurse Specialist, non-facility), effective Jan 1, 2023
  • VA: $0.59 (medical), effective Apr 1, 2023
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WA: $2.50 (professional_administered_drugs), effective Jul 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.